Not seeing too well

Since Momma Kliff told us never to gloat we won’t take too much credit for once again being right. Last week Verily, Google’s life sciences unit, halted development of their way cool whiz bang contact lenses which were supposed to measure glucose levels. Per a post on the CNBC website;

“But in a blog post on Friday, Verily said that after four years of research it has determined that detecting blood sugar in tears is a massive — and potentially insurmountable — technical and scientific undertaking.

“Our clinical work on the glucose-sensing lens demonstrated that there was insufficient consistency in our measurements of the correlation between tear glucose and blood glucose concentrations to support the requirements of a medical device,” the company said.”

Now we don’t want to say we told you so, but we did. Verily joins a long and distinguished list of companies who have spent millions seeking the Holy Grail of glucose measurement, a non-invasive method for measuring glucose. Yet Verily isn’t the only company in the Valley to put an end to their non-invasive efforts as their neighbors at Apple have also killed their way cool whiz-bang non-invasive toy.

At this point we could go into our normal rant about how this quest for the Holy Grail is a foolish endeavor. How even if successful this product isn’t needed and isn’t the sure-fire commercial success everyone thinks it would be. We could repeat that any company seeking the Grail would be better off buying lottery tickets to achieve riches. That the reason most patients don’t measure their glucose levels regularly has nothing to do with the test being invasive and everything to do with that patients do not understand or value the information.

We could mention that CGM is quickly becoming the standard for glucose measurement. That time in range is becoming a new metric for measuring what constitutes good control. That with the G6 and the Libre CGM is now very patient friendly and becoming more affordable too.

Perhaps this is the reason Apple is getting more active with Dexcom. It’s also likely Google who is also partnered with Dexcom sees greater potential in their slap it on turn it on sensor. A sensor which has the potential to forever change diabetes management and be a major commercial success over the way cool whiz bang now dead contact lenses.

Now you would think at this point with both Apple and Google giving up on their way cool whiz-bang non-invasive efforts money will stop flowing into this quest. Well you could think that, but you’d be wrong. Yep for just as the sun rises in the east and sets in the west there is no cure for stupid. Does it matter that millions have been wasted on this quest? Nope. As Momma Kliff used to say never underestimate ignorance.

If there is one thing, we can say about the toy makers is they just love tinkering with their toys. Never mind there is no reason or need to have these toys. That they won’t make a damn bit of difference when it comes to improving patient outcomes. Nope let’s throw money and waste lots of time making the impossible possible.

So, have at it boys and girls enjoy this foolish quest as there is one thing that comes from your efforts, great copy. Not like we need it but with this being the wacky world of diabetes it’s the one thing we have in abundance.